Ryan Paterson
Papers
1
Total Citations
49
H-Index
1
About
Dr. Ryan Paterson is a leading urological surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH), particularly for patients with complex, large-volume prostate glands. His major contributions are anchored in the clinical development and long-term validation of Aquablation therapy, a novel water-jet ablation technique. Dr. Paterson’s pivotal work on the WATER II clinical trial provides the most robust evidence to date for this technology. His landmark publication, "Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results" (2023), has garnered 49 citations, demonstrating its significant impact on clinical practice. This study established the procedure’s durable safety and efficacy for treating men with symptomatic BPH and large prostates, a historically challenging patient group. By rigorously documenting outcomes over five years, Dr. Paterson has provided surgeons and patients with critical data to guide treatment decisions, solidifying Aquablation as a viable alternative to traditional surgery for high-volume disease.
Research Focus
Key Achievements
Top Papers
- 1